XLK fell nearly 9% on the week to $180.77, and the short sellers who spent May building positions into a rising market are now sitting on gains — yet the data shows them pressing harder, not banking profits.
Short interest has accelerated rather than retreated. It climbed another 13% over the past week to 5.1% of free float — 16.7 million shares — extending a trend that began in late April. The month-on-month build is now almost 17%. The last note flagged bears adding into strength; they are now adding into a sharp drawdown, which shifts the character of the trade. This looks less like a hedge being maintained and more like a conviction short being pressed on momentum. The ORTEX short score has eased to 37.7 from a mid-week peak of 45.4 on June 3, which reflects the price decline doing some of the work — but the underlying short share count keeps rising.
The borrow market tells a different story from a month ago. Availability has actually loosened sharply, jumping back to 476% from just 191% on June 3 — the tightest reading of the past six weeks. That mid-week squeeze in availability has fully unwound. With 28.6 million shares now available to borrow and borrowing costs running at just 0.57%, the lending pool is wide open for anyone wanting to add to the short. There is no squeeze pressure here. The 52-week low availability was 40.6%, a level that feels remote from current conditions.
Options positioning has shifted in a way that stands out. The put/call ratio has dropped to 1.80, nearly two standard deviations below its 20-day average of 2.04. That is a notable change: for most of the past month, PCR ran well above 2.0, reflecting heavy demand for downside protection. The pullback in put activity — even as the stock fell 9% on the week — suggests options traders have been closing hedges rather than adding new ones, or that call buyers stepped in during the decline. At 1.80, PCR is now near its 52-week low of 1.34, a far cry from the defensive extremes seen earlier this year. The divergence between rising short interest and retreating put demand is the key tension worth tracking.
The institutional holder list offers some context on who is in the fund. Wells Fargo holds the largest disclosed position at 3.6% of shares, adding 628,000 shares through March 31. UBS Asset Management made the most aggressive move in the quarter, adding 3.4 million shares to reach a 2% stake. JPMorgan added 1.3 million shares. These are March 31 filings, so they predate the recent volatility — but the pattern of large financial institutions building into XLK through Q1 is worth noting as the ETF now trades roughly 9% below where it closed that quarter.
The setup heading into next week is a direct test of that divergence: short interest is at a multi-month high and still rising, but options hedgers appear to be stepping back just as the stock delivers the correction the bears were positioned for. Whether short sellers now trim and take profits — or treat $180 as the next level to defend — is the question the data will answer over the coming sessions.
See the live data behind this article on ORTEX.
Open XLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
